Part,  Chapter, Paragraph

 1   II,     5.  8.  2|        emphysema~J43.9~ ~Emphysema, unspecified~ ~ ~Emphysema (lung)(pulmonary):~·
 2   II,     5.  8.  2|            with acute exacerbation, unspecified~J44.8~ ~Other specified
 3   II,     5.  8.  2|      obstructive pulmonary disease, unspecified~ ~ ~Chronic obstructive:~·
 4   II,     5.  9.  2|         status asthmaticus 493.21~· Unspecified asthma without mention of
 5   II,     5.  9.  2|            Allergic rhinitis, cause unspecified 477.9~ ~An interesting survey (
 6   II,     5. 10.  2| Angioneurotic oedema~995.3~Allergy, unspecified~E865~Accidental poisoning
 7   II,     5. 10.  2|             intrinsic~493.9~Asthma, unspecified~495.9~Unspecified allergic
 8   II,     5. 10.  2|           Asthma, unspecified~495.9~Unspecified allergic alveolitis~496~
 9   II,     5. 10.  2|          elsewhere classified~995.2~Unspecified adverse effect of drug,
10   II,     5. 10.  2|           T78.2~Anaphylactic shock, unspecified~T78.3~Angioneurotic oedema~
11   II,     5. 10.  2| Angioneurotic oedema~T78.4~Allergy, unspecified~Source: EU SCOOP Report
12  III,    10.  4.  5|          energy recovery and 21% is unspecified. Therefore, land filling
13  III,    10.  4.  5|         energy recovery and 21 % is unspecified (data from 19 Member States).